Elanco Animal Health Inc [NYSE: ELAN] loss -0.68% on the last trading session, reaching $14.51 price per share at the time.
Elanco Animal Health Inc represents 496.46 million in outstanding shares, while the company has a total market value of $7.21 billion with the latest information. ELAN stock price has been found in the range of $14.375 to $14.665.
If compared to the average trading volume of 5.84M shares, ELAN reached a trading volume of 3796655 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Elanco Animal Health Inc [ELAN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ELAN shares is $15.09 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ELAN stock is a recommendation set at 1.73. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Elanco Animal Health Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 26, 2025. While these analysts kept the previous recommendation, UBS raised their target price to Buy. The new note on the price target was released on December 09, 2024, representing the official price target for Elanco Animal Health Inc stock. Previously, the target price had yet another raise to $14, while Leerink Partners analysts kept a Market Perform rating on ELAN stock. On September 19, 2024, analysts decreased their price target for ELAN shares from 17 to 15.
The Price to Book ratio for the last quarter was 1.13, with the Price to Cash per share for the same quarter was set at 0.98. Price to Free Cash Flow for ELAN in the course of the last twelve months was 20.77 with Quick ratio for the last quarter at 1.46.
Trading performance analysis for ELAN stock
Elanco Animal Health Inc [ELAN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.83. With this latest performance, ELAN shares gained by 5.07% in over the last four-week period, additionally plugging by 24.02% over the last 6 months – not to mention a rise of 19.82% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ELAN stock in for the last two-week period is set at 57.87, with the RSI for the last a single of trading hit 0.38, and the three-weeks RSI is set at 0.42 for Elanco Animal Health Inc [ELAN]. The present Moving Average for the last 50 days of trading for this stock 13.51, while it was recorded at 14.79 for the last single week of trading, and 12.23 for the last 200 days.
Elanco Animal Health Inc [ELAN]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Elanco Animal Health Inc [ELAN] shares currently have an operating margin of 5.40% and a Gross Margin at 43.10%. Elanco Animal Health Inc’s Net Margin is presently recorded at 8.43%.
Return on Equity for this stock inclined to 2.77%, with Return on Assets sitting at 2.77%. When it comes to the capital structure of this company, Elanco Animal Health Inc [ELAN] has a Total Debt to Total Equity ratio set at 0.69.
Reflecting on the efficiency of the workforce at the company, Elanco Animal Health Inc [ELAN] managed to generate an average of $39470.9 per employee.Elanco Animal Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.46 and a Current Ratio set at 2.71.
Elanco Animal Health Inc [ELAN]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ELAN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Elanco Animal Health Inc go to 6.29%.
An analysis of Institutional ownership at Elanco Animal Health Inc [ELAN]
There are presently around $101.48%, or 102.54% of ELAN stock, in the hands of institutional investors. The top three institutional holders of ELAN stocks are: DODGE & COX with ownership of 83.58 million shares, which is approximately 16.9128%. PRIMECAP MANAGEMENT CO/CA/, holding 52.8 million shares of the stock with an approximate value of $$761.94 million in ELAN stocks shares; and PRIMECAP MANAGEMENT CO/CA/, currently with $$713.53 million in ELAN stock with ownership which is approximately 10.0056%.
